Clinical implications of three new studies on treatments that may increase risk of—or mitigate harm from—stroke in older patients.
Mark L. Fuerst
Can treatment of subclinical hypothyroidism help diminish frequency and severity of migraines? This study suggests that levothyroxine can do both.
Can aspirin improve exercise endurance in people with MS? How best to treat children with MOG-Ab associated disease? What factors increase MS susceptibility?
Clinically useful Insights on multiple sclerosis culled from 3 presentations at the 7th Joint ECTRIMS-ACTRIMS conference are briefly summarized here.
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.
New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
Research includes impact of body weight on migraine risk, effect of sleep on MS relapse, and side effects of statins in stroke survivors.
Studies include stroke risk with epilepsy, genetic predisposition for ischemic stroke, and dysphagia screening in stroke patients.
Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.